This compound is a pharmaceutical intermediate used in borylation reactions, featuring a boron-containing dioxaborolane ring. Its significance lies in its role as a building block for introducing boron atoms into organic molecules.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1142363-56-1
Pyrazole-4-boronic acid pinacol ester
pharmaceutical intermediate
N-(5-(4-(hydroxymethyl)phenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide
pharmaceutical intermediate
N-(5-bromo-[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide
pharmaceutical intermediate
2-[2-[2-[[2-[2-(2-aminoethoxy)ethoxy]acetyl]amino]ethoxy]ethoxy]acetic acid
pharmaceutical intermediate
Fmoc-D-leucine
pharmaceutical intermediate
3,6-Dihydro-2H-pyran-4-boronic acid pinacol ester
pharmaceutical intermediate
4,4,5,5-tetramethyl-2-(2,2,6,6-tetramethyl-3H-pyran-4-yl)-1,3,2-dioxaborolane
VOXXPMAJNSVUKJ-UHFFFAOYSA-N
B1(OC(C(O1)(C)C)(C)C)C2=CC(OC(C2)(C)C)(C)C
—